Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Lactobacillus gasseri & Diarrhea-predominant Irritable Bowel Syndrome (IBS) (IBS-D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

In the context of Lactobacillus gasseri & Diarrhea-predominant Irritable Bowel Syndrome (IBS) (IBS-D), the clinical trial KCT0000969 demonstrated that Lactobacillus gasseri BNR17 can serve as a potential probiotic to alleviate Diarrhea-predominant Irritable Bowel Syndrome (IBS-D).

(1) Shin et al. 2018a J. Clin. Biochem. Nutr. 62:179–186

…

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome
Shin et al. 2018a J. Clin. Biochem. Nutr. 62:179–186

7/1/2026